Summary
Cardinal Health, Inc. (CAH) filed an 8-K report detailing the results of its 2024 Annual Meeting of Shareholders, held on November 6, 2024. The primary focus of the filing is the outcome of four key proposals voted upon by shareholders. Notably, all ten director nominees were elected to the board, indicating strong shareholder confidence in the current leadership and governance structure. Shareholders also approved, on a non-binding advisory basis, the compensation of the company's named executive officers, often referred to as the 'say-on-pay' vote, with a majority in favor. The ratification of Ernst & Young LLP as the independent auditor for the upcoming fiscal year also received overwhelming support. However, a shareholder proposal aimed at prohibiting the re-nomination of directors who fail to receive a majority vote was not approved, suggesting a preference among shareholders for the current director nomination and election process. Overall, the filing shows positive shareholder sentiment towards board composition, executive compensation, and auditor selection, while indicating a rejection of a specific governance change proposal.
Key Highlights
- 1All ten director nominees were elected to the Board of Directors, with substantial 'For' votes across the slate.
- 2Shareholders approved the compensation of named executive officers on a non-binding advisory basis ('say-on-pay') with a significant majority.
- 3The appointment of Ernst & Young LLP as the independent auditor for fiscal year 2025 was ratified with overwhelming support.
- 4A shareholder proposal to prohibit the re-nomination of directors failing to receive a majority vote was not approved.
- 5The election of directors generally saw very high 'For' votes, with some nominees receiving over 192 million 'For' votes.
- 6High levels of abstained votes and broker non-votes were present for director elections and the shareholder proposal.